GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » EPS (Diluted)

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) EPS (Diluted) : $0.00 (TTM As of Nov. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings EPS (Diluted)?

Cannabis Bioscience International Holdings's Earnings per Share (Diluted) for the six months ended in Nov. 2023 was $0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2023 was $0.00.

Cannabis Bioscience International Holdings's EPS (Basic) for the six months ended in Nov. 2023 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Nov. 2023 was $0.00.

Cannabis Bioscience International Holdings's EPS without NRI for the six months ended in Nov. 2023 was $0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Nov. 2023 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Cannabis Bioscience International Holdings EPS (Diluted) Historical Data

The historical data trend for Cannabis Bioscience International Holdings's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings EPS (Diluted) Chart

Cannabis Bioscience International Holdings Annual Data
Trend Dec06 Dec07 May09 May10 May11
EPS (Diluted)
-0.10 -0.20 7.40 -1.66 0.81

Cannabis Bioscience International Holdings Semi-Annual Data
Dec06 Jun07 Dec07 Jun08 May09 Nov09 May10 Nov10 May11 Nov11 Nov22 Nov23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.68 0.13 0.37 - -

Competitive Comparison of Cannabis Bioscience International Holdings's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Bioscience International Holdings's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's PE Ratio distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's PE Ratio falls into.



Cannabis Bioscience International Holdings EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Cannabis Bioscience International Holdings's Diluted EPS for the fiscal year that ended in May. 2011 is calculated as

Diluted EPS (A: May. 2011 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(10.457-0)/12.930
=0.81

Cannabis Bioscience International Holdings's Diluted EPS for the quarter that ended in Nov. 2023 is calculated as

Diluted EPS (Q: Nov. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.306-0)/10331.749
=-0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Nov. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Bioscience International Holdings  (OTCPK:CBIH) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Cannabis Bioscience International Holdings EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6201 Bonhomme Road, Suite 466S, Houston, TX, USA, 77036
Cannabis Bioscience International Holdings Inc is engaged in providing educational systems relating to cannabis and services in therapeutic areas. of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. The Company generates revenue from multiple streams, namely, clinical trials, consulting fees, video courses, seminars, royalties, and merchandise sales. The company generates the majority of its revenue from clinical trials.

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Headlines